BioStem (BSEM) Chief Accounting Officer Michael Fortunato Exercises & Disposes 4,234 Shares

What Happened

• Michael A. Fortunato, Chief Accounting Officer of BioStem Technologies (BSEM), reported an exercise/conversion of a derivative (transaction code M) for 4,234 shares on 2026-09-15 and a same‑day disposition of the same 4,234 shares. Both the acquisition and disposition were reported at $0.00, so the filing shows no cash paid or received.

Key Details

• Transaction date: 2026-09-15. Form 4 filed: 2026-09-17 (appears timely under the 2-business-day rule).
• Transaction codes: M (exercise or conversion of a derivative) for both the acquisition and disposition.
• Price(s) reported: $0.00 for both the acquired and disposed shares; total values reported as $0.
• Shares owned after the transaction: not specified in the excerpt provided.
• Footnotes included in the filing: F1–F9. These describe vesting schedules for various option grants and restricted stock units (RSUs) and clarify that (a) some options are fully vested and exercisable, (b) RSUs represent contingent rights to receive shares, and (c) several grants have staged vesting schedules (quarterly or yearly tranches).

Context

• Transaction code M means the insider exercised or converted a derivative security (for example, option exercise or conversion of RSUs); the immediate same‑day disposition indicates the shares were not held long after conversion. The $0.00 reported price means the filing does not show cash proceeds or an exercise price in this excerpt—this can occur with certain types of conversions, net settlements, or withholding arrangements, but the filing itself does not state the reason.
• This report is factual disclosure of insider activity; it does not explain the insider’s motives.